Citation Impact
Citing Papers
Genome sequence of an industrial microorganism Streptomyces avermitilis : Deducing the ability of producing secondary metabolites
2001 StandoutNobel
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
2008 StandoutScience
The metabolism of 16-fluoroestradiols in vivo: Chemical strategies for restricting the oxidative biotransformations of an estrogen-receptor imaging agent
1997
Cyclodextrins as pharmaceutical solubilizers
2007 Standout
B‐cell dysfunction and depletion using mycophenolate mofetil in a pediatric combined liver and kidney graft recipient
2001
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study
2000 Standout
High-performance liquid chromatographic method for the determination of mycophenolate mofetil in human plasma
1996
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
2015 StandoutNobel
Efficient and Economical Access to Substituted Benzothiazoles: Copper‐Catalyzed Coupling of 2‐Haloanilides with Metal Sulfides and Subsequent Condensation
2009
Cross-Talk between Gs- and Gq-Coupled Pathways in Regulation of Interleukin-4 by A2B Adenosine Receptors in Human Mast Cells
2006
Copper‐Catalyzed Direct C Arylation of Heterocycles with Aryl Bromides: Discovery of Fluorescent Core Frameworks
2009
Marine natural products
1990 Standout
Inhaled Glucocorticoids for Asthma
1995
Adenosine receptors as therapeutic targets
2006 Standout
Mechanism-Based Inactivation (MBI) of Cytochrome P450 Enzymes: Structure–Activity Relationships and Discovery Strategies To Mitigate Drug–Drug Interaction Risks
2012
Pharmacokinetics and Bioavailability of Mycophenolate Mofetil in Healthy Subjects after Single‐Dose Oral and Intravenous Administration
1996
Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma
2007
Synthesis of Extended π‐Systems through C–H Activation
2014 Standout
Asthma
2017 Standout
Clinical Pharmacokinetics of Mycophenolate Mofetil
1998 Standout
Pathophysiology and Therapeutic Potential of Purinergic Signaling
2006
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Use of nasal steroids in managing allergic rhinitis
1999
Ranolazine for chronic stable angina
2008
Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer
2010
Systemic Adverse Effects of Inhaled Corticosteroid Therapy
1999
Circadian control of the immune system
2013 Standout
Modern Synthetic Methods for Copper‐Mediated C(aryl)O, C(aryl)N, and C(aryl)S Bond Formation
2003 Standout
Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis
2003 StandoutNobel
Progress in the pursuit of therapeutic adenosine receptor antagonists
2005
How were new medicines discovered?
2011 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Phosphine‐Free, Palladium‐Catalyzed Arylation of Heterocycles through CH Bond Activation with Pivalic Acid as a Cocatalyst
2008
Pharmacokinetics and systemic activity of fluticasone via Diskus® and pMDI, and of budesonide via Turbuhaler®
2001
Cellular Fatty Acid Metabolism and Cancer
2013 Standout
Ranolazine, a Novel Agent for Chronic Stable Angina
2006
Identification and SAR around N-{2-[4-(2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-[1,4]diazepan-1-yl]-ethyl}-2-phenoxy-nicotinamide, a selective α2C adrenergic receptor antagonist
2008
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
2008 Standout
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Adenosine in the airways: Implications and applications
2006
Discovery of potent and liver-targeted stearoyl-CoA desaturase (SCD) inhibitors in a bispyrrolidine series
2011
Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings
1997
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
2001 Standout
A Comparison between Ranolazine and CVT-4325, a Novel Inhibitor of Fatty Acid Oxidation, on Cardiac Metabolism and Left Ventricular Function in Rat Isolated Perfused Heart during Ischemia and Reperfusion
2007
Transition‐Metal‐Catalyzed Direct Arylation of (Hetero)Arenes by CH Bond Cleavage
2009 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Pharmaceutically active secondary metabolites of microorganisms
1999
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
2016 StandoutNobel
MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTS
1997
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Asthma
2000 Standout
Do Inhaled Corticosteroids Inhibit Growth in Children?
2001
5 Amidines and Guanidines in Medicinal Chemistry
1993
A Fluorogenic Aryl Fluorosulfate for Intraorganellar Transthyretin Imaging in Living Cells and in Caenorhabditis elegans
2015 StandoutNobel
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Copper-Mediated Coupling Reactions and Their Applications in Natural Products and Designed Biomolecules Synthesis
2008 Standout
3d Transition Metals for C–H Activation
2018 Standout
Fluorine in medicinal chemistry
2007 Standout
Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression by measuring IMP dehydrogenase activity
1995
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
2-Amino-6-furan-2-yl-4-substituted Nicotinonitriles as A2A Adenosine Receptor Antagonists
2008
Complete N-1 Regiocontrol in the Formation of N-Arylimidazoles. Synthesis of the Active Site His-Tyr Side Chain Coupled Dipeptide of Cytochrome c Oxidase
2000
Ranolazine for the Treatment of Chronic Angina and Potential Use in Other Cardiovascular Conditions
2006
Erythrazoles A–B, Cytotoxic Benzothiazoles from a Marine-DerivedErythrobactersp.
2011
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates
2011 Standout
Mechanistic Studies on the Cu-Catalyzed Three-Component Reactions of Sulfonyl Azides, 1-Alkynes and Amines, Alcohols, or Water: Dichotomy via a Common Pathway
2008 StandoutNobel
Enteric-Coated Mycophenolate Sodium
2003
Additions to Metal-Activated Organonitriles
2002 Standout
Carboxylate-Assisted Transition-Metal-Catalyzed C−H Bond Functionalizations: Mechanism and Scope
2011 Standout
Copper‐Catalyzed Direct C Arylation of Heterocycles with Aryl Bromides: Discovery of Fluorescent Core Frameworks
2009
Diversifying Carotenoid Biosynthetic Pathways by Directed Evolution
2005 StandoutNobel
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association
2016
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Cytochrome P-450—Catalyzed Formation of Δ4-VPA, a Toxic Metabolite of Valproic Acid
1987 Science
An Efficient Diamine·Copper Complex-Catalyzed Coupling of Arylboronic Acids with Imidazoles
2000
1-Substituted 4-(3-Hydroxyphenyl)piperazines Are Pure Opioid Receptor Antagonists
2010
Practical Asymmetric Synthesis of a Non-Peptidic αvβ3 Antagonist
2005
Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils
1997 StandoutNobel
The human pharmacology of fluticasone propionate
1990
Transition-Metal-Catalyzed C−S, C−Se, and C−Te Bond Formation via Cross-Coupling and Atom-Economic Addition Reactions
2011 Standout
Effect of various cyclodextrins on solution stability and dissolution rate of doxorubicin hydrochloride
1992
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Aerobic Copper-Catalyzed Organic Reactions
2013 Standout
Manual and automated (robotic) high-performance liquid chromatography methods for the determination of mycophenolic acid and its glucuronide conjugate in human plasma
1996
A Comparison of Intranasal and Oral Flunisolide in the Therapy of Allergic Rhinitis
1985
Large-Scale Applications of Transition Metal-Catalyzed Couplings for the Synthesis of Pharmaceuticals
2011 Standout
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2016 Standout
Synthetic Approaches and Pharmacological Activity of 1,3,4-Oxadiazoles: A Review of the Literature from 2000–2012
2012
Heme-Containing Oxygenases
1996 Standout
Direct C−H Transformation via Iron Catalysis
2010 Standout
Catalytic Activities of Cu(II) Complexes with Nitrogen-Chelating Bidentate Ligands in the Coupling of Imidazoles with Arylboronic Acids
2001
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Aryl−Aryl Bond Formation One Century after the Discovery of the Ullmann Reaction
2002 Standout
The Copper-Mediated Cross-Coupling of Phenylboronic Acids and N-Hydroxyphthalimide at Room Temperature: Synthesis of Aryloxyamines
2000 StandoutNobel
Works of Nancy Chu being referenced
CVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailability
2004
Inhibitors of cyclic AMP phosphodiesterase. 4. Synthesis and evaluation of potential prodrugs of lixazinone (N-cyclohexyl-N-methyl-4-[(1,2,3,5-tetrahydro-2-oxoimidazo[2,1-b]quinazolin-7-yl)oxy]butyramide, RS-82856)
1988
Orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors
2009
Bioavailability Improvement of Mycophenolic Acid Through Amino Ester Derivatization
1990
Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists
2007
The discovery of a selective, high affinity A2B adenosine receptor antagonist for the potential treatment of asthma
2004
Studies to Investigate the Pharmacokinetic Interactions Between Ranolazine and Ketoconazole, Diltiazem, or Simvastatin During Combined Administration in Healthy Subjects
2005
New fatty acid oxidation inhibitors with increased potency lacking adverse metabolic and electrophysiological properties
2003
Mechanism for the oxidative defluorination of flunisolide.
1981
Preformulation Selection of a Proper Salt for a Weak Acid-Base (Rs-82856) - A New Positive Inotropic Agent
1987
Flunisolide metabolism and dynamics of a metabolite
1980
Enhancement of Solubility, Dissolution Rate, and Oral Bioavailability of Rs-82856 by Complex Formation with Cyclodextrins
1989